Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 5:47 pm Purchase | 13G | Applied Therapeutics Inc. APLT | Venrock Healthcare Capital Partners III L.P. | 11,656,065 9.990% | 3,778,248 (+47.96%) | View |
| 2024-11-14 4:50 pm Purchase | 13G | Applied Therapeutics Inc. APLT | PERCEPTIVE ADVISORS LLC | 10,005,000 8.500% | 5,424,751 (+118.44%) | View |
| 2024-11-14 4:38 pm Sale | 13G | Applied Therapeutics Inc. APLT | Alyeska Investment Group L.P. | 4,981,673 4.200% | -2,733,524 (-35.43%) | View |
| 2024-11-14 1:35 pm Purchase | 13G | Applied Therapeutics Inc. APLT | JANUS HENDERSON GROUP PLC JHG | 10,541,528 9.200% | 4,126,886 (+64.34%) | View |
| 2024-11-14 12:00 pm Sale | 13G | Applied Therapeutics Inc. APLT | Vestal Point Capital LP | 1,145,000 1.000% | -3,010,000 (-72.44%) | View |
| 2024-11-13 4:15 pm Sale | 13G | Applied Therapeutics Inc. APLT | ALEXANDRIA REAL ESTATE EQUITIES INC. ARE | 12,559,054 10.300% | -300,000 (-2.33%) | View |
| 2024-11-08 2:17 pm Unchanged | 13G | Applied Therapeutics Inc. APLT | BlackRock Inc. BLK | 6,942,699 6.000% | 0 (Unchanged) | View |
| 2024-11-06 4:38 pm Purchase | 13G | Applied Therapeutics Inc. APLT | MORGAN STANLEY MS | 9,901,213 8.600% | 9,901,213 (New Position) | View |
| 2024-10-24 2:02 pm Purchase | 13G | Applied Therapeutics Inc. APLT | BlackRock Inc. BLK | 6,942,699 6.000% | 6,942,699 (New Position) | View |
| 2024-08-14 6:52 pm Sale | 13D | Applied Therapeutics Inc. APLT | Shendelman Shoshana | 7,803,355 6.600% | -843,536 (-9.76%) | View |
| 2024-03-08 3:17 pm Purchase | 13G | Applied Therapeutics Inc. APLT | JANUS HENDERSON GROUP PLC JHG | 6,414,642 6.100% | 6,414,642 (New Position) | View |
| 2024-03-05 5:42 pm Purchase | 13D | Applied Therapeutics Inc. APLT | Shendelman Shoshana | 8,646,891 8.200% | 565,946 (+7.00%) | View |
| 2024-02-22 2:26 pm Purchase | 13G | Applied Therapeutics Inc. APLT | Propel Bio Management LLC | 8,071,526 10.500% | 3,314,144 (+69.66%) | View |
| 2024-02-14 9:20 pm Purchase | 13G | Applied Therapeutics Inc. APLT | Venrock Healthcare Capital Partners III L.P. | 7,877,817 9.990% | 2,080,232 (+35.88%) | View |
| 2024-02-14 6:30 pm Sale | 13G | Applied Therapeutics Inc. APLT | ORBIMED ADVISORS LLC | 0 0.000% | -7,300,921 (Position Closed) | View |
| 2024-02-14 4:52 pm Unchanged | 13G | Applied Therapeutics Inc. APLT | PERCEPTIVE ADVISORS LLC | 4,580,249 5.900% | 0 (Unchanged) | View |
| 2024-02-14 4:22 pm Sale | 13G | Applied Therapeutics Inc. APLT | ALEXANDRIA REAL ESTATE EQUITIES INC. ARE | 12,859,054 15.400% | -575,000 (-4.28%) | View |
| 2024-02-14 2:40 pm Sale | 13G | Applied Therapeutics Inc. APLT | ARMISTICE CAPITAL LLC | 0 0.000% | -5,333,951 (Position Closed) | View |
| 2024-02-14 1:50 pm Purchase | 13G | Applied Therapeutics Inc. APLT | Alyeska Investment Group L.P. | 7,715,197 9.990% | 2,910,197 (+60.57%) | View |
| 2024-02-13 4:34 pm Purchase | 13G | Applied Therapeutics Inc. APLT | Vestal Point Capital LP | 4,155,000 5.400% | 4,155,000 (New Position) | View |